drugset / Trial / NCT03067701

Effects of Carbon Monoxide Breathing on Blood Vessel Function

NCT03067701

Phase 1 Completed 9 enrolled Cedars-Sinai Medical Center
NaSingle-groupOpen-labelOther

Summary

In healthy young adults 18-39 years of age, the investigators will determine if intermittent inhalation a 0.1% CO, from a 1-liter bag once every minute for 30-40 minutes, at a level that approaches the CO boost with hookah smoking, augments endothelial function, thus implicating CO as the major endothelial vasodilator substance in hookah smoke. Rationale: Our group has demonstrated (PRO36547) that in contrast to cigarette smoking, hookah smoking (tobacco heated with charcoal) acutely augments, rather than impairs, brachial artery FMD. Importantly, our data strongly implicate-but do not prove-that the augmentation in FMD is caused by CO. Therefore; the investigators would like to extend the scientific priority of this work by directly investigating cause and effect of CO breathing (similar levels than ones obtained after hookah smoking) on brachial artery FMD.

Timeline

Start
2017-06-23
Primary completion
2018-12-01
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbon Monoxide Other / unclassified 0.1 % Inhaled

Indications

No indication recorded.